SR9009 / Stenabolic

Exercise mimetic / Circadian

Endurance/metabolic-circadian pathway positioning

Reading this compound Reference only

Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.

Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.

Mechanism & Use

Compound type: Small molecule
Primary mechanism: REV-ERB agonism
Primary market use: Performance/metabolic

Pharmacology

Molecular weight (Da): 437.5
Oral bioavailability: Poor oral / low
Half-life: ~4 h
Route tags: Route-dependent / verify
Evidence level: Preclinical
Clinical status: Research/prohibited risk
Value-for-money score: 3 / 10

Reported protocol signal

No popular protocol verified yet; keep as reference compound until protocol signal is added.

For orientation only. See disclaimer — always consult a licensed clinician before use.

Notes

Transient receptor pharmacology

Sources

https://www.wada-ama.org/en/prohibited-list